ID TNR11_MOUSE Reviewed; 625 AA.
AC O35305; Q8VCT7;
DT 26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT 01-JAN-1998, sequence version 1.
DT 04-NOV-2026, entry version 179.
DE RecName: Full=Tumor necrosis factor receptor superfamily member 11A;
DE AltName: Full=Osteoclast differentiation factor receptor;
DE Short=ODFR;
DE AltName: Full=Receptor activator of NF-KB;
DE AltName: CD_antigen=CD265;
DE Flags: Precursor;
GN Name=Tnfrsf11a; Synonyms=Rank;
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC TISSUE=Fetal liver;
RX PubMed=9367155; DOI=10.1038/36593;
RA Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C.,
RA Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., Galibert L.;
RT "A homologue of the TNF receptor and its ligand enhance T-cell growth and
RT dendritic-cell function.";
RL Nature 390:175-179(1997).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Mammary gland;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [3]
RP FUNCTION.
RX PubMed=9878548; DOI=10.1006/bbrc.1998.9788;
RA Nakagawa N., Kinosaki M., Yamaguchi K., Shima N., Yasuda H., Yano K.,
RA Morinaga T., Higashio K.;
RT "RANK is the essential signaling receptor for osteoclast differentiation
RT factor in osteoclastogenesis.";
RL Biochem. Biophys. Res. Commun. 253:395-400(1998).
RN [4]
RP FUNCTION, IDENTIFICATION IN A COMPLEX WITH EEIG1; PLCY2; GAB2; TEC AND BTK,
RP INTERACTION WITH EEIG1, AND SUBCELLULAR LOCATION.
RX PubMed=23478294; DOI=10.1038/cr.2013.33;
RA Choi H.K., Kang H.R., Jung E., Kim T.E., Lin J.J., Lee S.Y.;
RT "Early estrogen-induced gene 1, a novel RANK signaling component, is
RT essential for osteoclastogenesis.";
RL Cell Res. 23:524-536(2013).
RN [5]
RP INTERACTION WITH STAC2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP 532-GLY--ILE-534; 535-ILE--VAL-537; 538-TYR--SER-540 AND 541-GLN--SER-543.
RX PubMed=29348675; DOI=10.1038/s41418-017-0048-5;
RA Jeong E., Choi H.K., Park J.H., Lee S.Y.;
RT "STAC2 negatively regulates osteoclast formation by targeting the RANK
RT signaling complex.";
RL Cell Death Differ. 25:1364-1374(2018).
RN [6]
RP X-RAY CRYSTALLOGRAPHY ALONE AND IN COMPLEX WITH TNFSF11, DISULFIDE BONDS,
RP FUNCTION, SODIUM-BINDING SITE, AND SUBUNIT.
RX PubMed=20483727; DOI=10.4049/jimmunol.0904033;
RA Liu C., Walter T.S., Huang P., Zhang S., Zhu X., Wu Y., Wedderburn L.R.,
RA Tang P., Owens R.J., Stuart D.I., Ren J., Gao B.;
RT "Structural and functional insights of RANKL-RANK interaction and
RT signaling.";
RL J. Immunol. 184:6910-6919(2010).
RN [7]
RP X-RAY CRYSTALLOGRAPHY IN COMPLEX WITH TNFSF11/RANKL, DISULFIDE BONDS, AND
RP GLYCOSYLATION AT ASN-106.
RX PubMed=23039992; DOI=10.1016/j.str.2012.08.030;
RA Nelson C.A., Warren J.T., Wang M.W., Teitelbaum S.L., Fremont D.H.;
RT "RANKL employs distinct binding modes to engage RANK and the
RT osteoprotegerin decoy receptor.";
RL Structure 20:1971-1982(2012).
CC -!- FUNCTION: Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-
CC mediated osteoclastogenesis (PubMed:20483727, PubMed:23478294,
CC PubMed:9878548). Its interaction with EEIG1 promotes osteoclastogenesis
CC via facilitating the transcription of NFATC1 and activation of PLCG2
CC (PubMed:23478294). Involved in the regulation of interactions between
CC T-cells and dendritic cells (PubMed:9367155).
CC {ECO:0000269|PubMed:20483727, ECO:0000269|PubMed:23478294,
CC ECO:0000269|PubMed:9367155, ECO:0000269|PubMed:9878548}.
CC -!- SUBUNIT: Binds to the clefts between the subunits of the TNFSF11 ligand
CC trimer to form a heterohexamer (PubMed:20483727, PubMed:23039992). Part
CC of a complex composed of EEIG1, TNFRSF11A/RANK, PLCG2, GAB2, TEC and
CC BTK; complex formation increases in the presence of TNFSF11/RANKL
CC (PubMed:23478294, PubMed:29348675). Interacts with TRAF1, TRAF2, TRAF3,
CC TRAF5 and TRAF6 (By similarity). Interacts (via cytoplasmic domain)
CC with GAB2 (By similarity). Interacts (via cytoplasmic domain); with
CC EEIG1 (via N-terminus); when in the presence of TNFSF11/RANKL
CC (PubMed:23478294). After TNFSF11 stimulation, interacts (via IVVY
CC motif) with STAC2; this interaction affects TNFRSF11A interaction with
CC PLCG2 and GAB2 (PubMed:29348675). {ECO:0000250|UniProtKB:Q9Y6Q6,
CC ECO:0000269|PubMed:20483727, ECO:0000269|PubMed:23039992,
CC ECO:0000269|PubMed:23478294, ECO:0000269|PubMed:29348675}.
CC -!- INTERACTION:
CC O35305; Q9Z1R2: Bag6; NbExp=4; IntAct=EBI-647362, EBI-644645;
CC O35305; O35235-1: Tnfsf11; NbExp=6; IntAct=EBI-647362, EBI-15890886;
CC O35305; P39429: Traf2; NbExp=2; IntAct=EBI-647362, EBI-520016;
CC O35305; Q60803: Traf3; NbExp=3; IntAct=EBI-647362, EBI-520135;
CC O35305; P70196: Traf6; NbExp=2; IntAct=EBI-647362, EBI-448028;
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9Y6Q6};
CC Single-pass type I membrane protein {ECO:0000255}. Membrane raft
CC {ECO:0000269|PubMed:23478294, ECO:0000269|PubMed:29348675}.
CC Note=Following TNFSF11/RANKL stimulation, recruited to lipid rafts
CC along with STAC2. {ECO:0000269|PubMed:29348675}.
CC -!- TISSUE SPECIFICITY: Ubiquitous expression with high levels in
CC trabecular bone, thymus, small intestine, lung, brain and kidney.
CC Weakly expressed in spleen and bone marrow.
CC -!- DOMAIN: The IVVY motif is required for efficient interaction with
CC STAC2. {ECO:0000269|PubMed:29348675}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF019046; AAB86810.1; -; mRNA.
DR EMBL; BC019185; AAH19185.1; -; mRNA.
DR CCDS; CCDS15207.1; -.
DR RefSeq; NP_033425.3; NM_009399.5.
DR PDB; 3ME2; X-ray; 2.80 A; R=26-210.
DR PDB; 3ME4; X-ray; 2.01 A; A/B=26-210.
DR PDB; 3QBQ; X-ray; 2.50 A; B/D=32-201.
DR PDB; 4GIQ; X-ray; 2.70 A; R=31-198.
DR PDB; 5BNQ; X-ray; 2.80 A; R=26-210.
DR AlphaFoldDB; O35305; -.
DR SMR; O35305; -.
DR BioGRID; 204246; 5.
DR CORUM; O35305; -.
DR DIP; DIP-48710N; -.
DR ELM; O35305; -.
DR FunCoup; O35305; 548.
DR IntAct; O35305; 11.
DR STRING; 10090.ENSMUSP00000027559; -.
DR GlyCosmos; O35305; 2 sites, 1 glycan.
DR GlyGen; O35305; 2 sites, 1 N-linked glycan (1 site).
DR iPTMnet; O35305; -.
DR PhosphoSitePlus; O35305; -.
DR PaxDb; 10090-ENSMUSP00000027559; -.
DR PeptideAtlas; O35305; -.
DR ProteomicsDB; 260632; -.
DR Antibodypedia; 4165; 918 antibodies from 48 providers.
DR DNASU; 21934; -.
DR Ensembl; ENSMPUT00000016649; ENSMPUP00000016404; ENSMPUG00000016507.
DR Ensembl; ENSMUST00000027559.9; ENSMUSP00000027559.7; ENSMUSG00000026321.9.
DR GeneID; 21934; -.
DR KEGG; mmu:21934; -.
DR UCSC; uc007cgp.1; mouse.
DR AGR; MGI:1314891; -.
DR CTD; 8792; -.
DR MGI; MGI:1314891; Tnfrsf11a.
DR VEuPathDB; HostDB:ENSMUSG00000026321; -.
DR eggNOG; ENOG502RWJI; Eukaryota.
DR GeneTree; ENSGT00940000161211; -.
DR HOGENOM; CLU_026571_0_0_1; -.
DR InParanoid; O35305; -.
DR OMA; AAMLCLW; -.
DR OrthoDB; 9889060at2759; -.
DR PhylomeDB; O35305; -.
DR Reactome; R-MMU-5668541; TNFR2 non-canonical NF-kB pathway.
DR Reactome; R-MMU-5676594; TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway.
DR BioGRID-ORCS; 21934; 2 hits in 76 CRISPR screens.
DR EvolutionaryTrace; O35305; -.
DR PRO; PR:O35305; -.
DR Proteomes; UP000000589; Chromosome 1.
DR RNAct; O35305; protein.
DR Bgee; ENSMUSG00000026321; Expressed in left colon and 83 other cell types or tissues.
DR GO; GO:0009986; C:cell surface; IDA:MGI.
DR GO; GO:0005829; C:cytosol; ISO:GO_Central.
DR GO; GO:0009897; C:external side of plasma membrane; ISO:GO_Central.
DR GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR GO; GO:0019955; F:cytokine binding; ISO:GO_Central.
DR GO; GO:0004888; F:transmembrane signaling receptor activity; ISO:GO_Central.
DR GO; GO:0005031; F:tumor necrosis factor receptor activity; IMP:BHF-UCL.
DR GO; GO:0002250; P:adaptive immune response; ISO:GO_Central.
DR GO; GO:0034224; P:cellular response to zinc ion starvation; IEA:Ensembl.
DR GO; GO:0060086; P:circadian temperature homeostasis; IMP:BHF-UCL.
DR GO; GO:0048535; P:lymph node development; IMP:MGI.
DR GO; GO:0060749; P:mammary gland alveolus development; IMP:MGI.
DR GO; GO:0072674; P:multinuclear osteoclast differentiation; IMP:MGI.
DR GO; GO:0001503; P:ossification; IMP:MGI.
DR GO; GO:0030316; P:osteoclast differentiation; ISO:GO_Central.
DR GO; GO:0045780; P:positive regulation of bone resorption; IMP:MGI.
DR GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISO:GO_Central.
DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:GO_Central.
DR GO; GO:0071812; P:positive regulation of fever generation by positive regulation of prostaglandin secretion; IMP:BHF-UCL.
DR GO; GO:0046330; P:positive regulation of JNK cascade; ISO:GO_Central.
DR GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:GO_Central.
DR GO; GO:0045672; P:positive regulation of osteoclast differentiation; IMP:UniProtKB.
DR GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR GO; GO:0070555; P:response to interleukin-1; IMP:BHF-UCL.
DR GO; GO:0032496; P:response to lipopolysaccharide; IMP:BHF-UCL.
DR GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR GO; GO:0034612; P:response to tumor necrosis factor; IMP:BHF-UCL.
DR GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:BHF-UCL.
DR CDD; cd13411; TNFRSF11A; 1.
DR FunFam; 2.10.50.10:FF:000015; TNF receptor superfamily member 11a; 1.
DR FunFam; 2.10.50.10:FF:000019; Tumor necrosis factor receptor superfamily member 11A; 1.
DR Gene3D; 2.10.50.10; Tumor Necrosis Factor Receptor, subunit A, domain 2; 2.
DR InterPro; IPR041648; RANK_CRD_2.
DR InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
DR InterPro; IPR022323; TNFR_11.
DR InterPro; IPR022361; TNFR_11A.
DR InterPro; IPR053075; TNFRSF11A.
DR InterPro; IPR034040; TNFRSF11A_N.
DR PANTHER; PTHR47134; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 11A; 1.
DR PANTHER; PTHR47134:SF1; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 11A; 1.
DR Pfam; PF18278; RANK_CRD_2; 1.
DR Pfam; PF00020; TNFR_c6; 1.
DR PRINTS; PR01961; TNFACTORR11.
DR PRINTS; PR01974; TNFACTORR11A.
DR SMART; SM00208; TNFR; 4.
DR SUPFAM; SSF57586; TNF receptor-like; 2.
DR PROSITE; PS00652; TNFR_NGFR_1; 1.
DR PROSITE; PS50050; TNFR_NGFR_2; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Cell membrane; Disulfide bond; Glycoprotein; Membrane;
KW Metal-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW Signal; Sodium; Transmembrane; Transmembrane helix.
FT SIGNAL 1..30
FT /evidence="ECO:0000255"
FT CHAIN 31..625
FT /note="Tumor necrosis factor receptor superfamily member
FT 11A"
FT /id="PRO_0000034586"
FT TOPO_DOM 31..214
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 215..234
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 235..625
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT REPEAT 35..69
FT /note="TNFR-Cys 1"
FT REPEAT 72..113
FT /note="TNFR-Cys 2"
FT REPEAT 115..152
FT /note="TNFR-Cys 3"
FT REPEAT 155..195
FT /note="TNFR-Cys 4"
FT REGION 331..356
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 388..413
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 479..524
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 532..537
FT /note="Required for interaction with EEIG1 and osteoclast
FT differentiation"
FT /evidence="ECO:0000269|PubMed:23478294"
FT REGION 542..625
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOTIF 535..538
FT /note="IVVY motif"
FT COMPBIAS 499..511
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 512..524
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 543..558
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 561..571
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 603..625
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 134
FT /ligand="Na(+)"
FT /ligand_id="ChEBI:CHEBI:29101"
FT BINDING 135
FT /ligand="Na(+)"
FT /ligand_id="ChEBI:CHEBI:29101"
FT BINDING 138
FT /ligand="Na(+)"
FT /ligand_id="ChEBI:CHEBI:29101"
FT BINDING 161
FT /ligand="Na(+)"
FT /ligand_id="ChEBI:CHEBI:29101"
FT BINDING 163
FT /ligand="Na(+)"
FT /ligand_id="ChEBI:CHEBI:29101"
FT MOD_RES 571
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q9Y6Q6"
FT CARBOHYD 106
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000269|PubMed:23039992"
FT CARBOHYD 175
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 35..47
FT DISULFID 48..61
FT DISULFID 51..69
FT DISULFID 72..87
FT DISULFID 93..113
FT DISULFID 115..128
FT DISULFID 125..127
FT DISULFID 134..152
FT DISULFID 155..170
FT DISULFID 176..195
FT MUTAGEN 532..534
FT /note="GDI->AAA: Some decrease in interaction with STAC2."
FT /evidence="ECO:0000269|PubMed:29348675"
FT MUTAGEN 535..537
FT /note="IVV->AAA: Almost complete loss of interaction with
FT STAC2."
FT /evidence="ECO:0000269|PubMed:29348675"
FT MUTAGEN 538..540
FT /note="YVS->AAA: Almost complete loss of interaction with
FT STAC2."
FT /evidence="ECO:0000269|PubMed:29348675"
FT MUTAGEN 541..543
FT /note="QTS->AAA: No effect on interaction with STAC2."
FT /evidence="ECO:0000269|PubMed:29348675"
FT CONFLICT 494
FT /note="R -> K (in Ref. 2; AAH19185)"
FT /evidence="ECO:0000305"
FT TURN 37..39
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 40..43
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 46..49
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 55..59
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 63..65
FT /evidence="ECO:0007829|PDB:3QBQ"
FT STRAND 68..71
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 80..82
FT /evidence="ECO:0007829|PDB:3ME4"
FT HELIX 90..93
FT /evidence="ECO:0007829|PDB:3ME4"
FT HELIX 95..97
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 99..103
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 107..109
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 112..115
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 119..122
FT /evidence="ECO:0007829|PDB:3ME4"
FT TURN 123..126
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 127..130
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 138..140
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 142..145
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 146..148
FT /evidence="ECO:0007829|PDB:4GIQ"
FT STRAND 152..154
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 165..167
FT /evidence="ECO:0007829|PDB:3ME4"
FT HELIX 176..179
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 183..185
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 189..191
FT /evidence="ECO:0007829|PDB:3ME4"
FT STRAND 194..196
FT /evidence="ECO:0007829|PDB:3QBQ"
SQ SEQUENCE 625 AA; 66621 MW; F8C1872E99511D8E CRC64;
MAPRARRRRQ LPAPLLALCV LLVPLQVTLQ VTPPCTQERH YEHLGRCCSR CEPGKYLSSK
CTPTSDSVCL PCGPDEYLDT WNEEDKCLLH KVCDAGKALV AVDPGNHTAP RRCACTAGYH
WNSDCECCRR NTECAPGFGA QHPLQLNKDT VCTPCLLGFF SDVFSSTDKC KPWTNCTLLG
KLEAHQGTTE SDVVCSSSMT LRRPPKEAQA YLPSLIVLLL FISVVVVAAI IFGVYYRKGG
KALTANLWNW VNDACSSLSG NKESSGDRCA GSHSATSSQQ EVCEGILLMT REEKMVPEDG
AGVCGPVCAA GGPWAEVRDS RTFTLVSEVE TQGDLSRKIP TEDEYTDRPS QPSTGSLLLI
QQGSKSIPPF QEPLEVGEND SLSQCFTGTE STVDSEGCDF TEPPSRTDSM PVSPEKHLTK
EIEGDSCLPW VVSSNSTDGY TGSGNTPGED HEPFPGSLKC GPLPQCAYSM GFPSEAAASM
AEAGVRPQDR ADERGASGSG SSPSDQPPAS GNVTGNSNST FISSGQVMNF KGDIIVVYVS
QTSQEGPGSA EPESEPVGRP VQEETLAHRD SFAGTAPRFP DVCATGAGLQ EQGAPRQKDG
TSRPVQEQGG AQTSLHTQGS GQCAE
//